These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16267733)

  • 21. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.
    Honda T; Katano Y; Urano F; Murayama M; Hayashi K; Ishigami M; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
    J Gastroenterol Hepatol; 2007 Jul; 22(7):989-95. PubMed ID: 17608843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
    Scherzer TM; Reddy KR; Wrba F; Hofer H; Staufer K; Steindl-Munda P; Gangl A; Ferenci P
    J Viral Hepat; 2008 Sep; 15(9):659-65. PubMed ID: 18637075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
    Szanto P; Grigorescu M; Dumitru I; Serban A
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists].
    Hofmann WP; Bock H; Weber C; Tacke W; Pfaff R; Kihn R; Moog G; Kellner HU; Schöfer M; Frick B; Berg P; Rambow A; Friedrich-Rust M; Herrmann E; Sarrazin C; Zeuzem S
    Z Gastroenterol; 2006 Jan; 44(1):25-31. PubMed ID: 16397836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
    Muir AJ; Sylvestre PB; Rockey DC
    J Viral Hepat; 2006 May; 13(5):322-8. PubMed ID: 16637863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual benefit from intramuscular interferon-beta treatment in a patient with multiple sclerosis and chronic hepatitis-C virus infection.
    Tan FU; Cetinkaya H; Erden E; Ulkatan S; Aydin N
    Hepatogastroenterology; 2002; 49(48):1686-7. PubMed ID: 12397766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus.
    Jarrett M; Cox P
    Nurs Clin North Am; 2004 Mar; 39(1):219-29. PubMed ID: 15062738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver disorders in the elderly.
    Floreani A
    Best Pract Res Clin Gastroenterol; 2009; 23(6):909-17. PubMed ID: 19942167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of thrombocytopenia in patients with chronic hepatitis C: more than meets the eye.
    Giannini EG; Savarino V
    J Viral Hepat; 2011 Jan; 18(1):8-10. PubMed ID: 20796207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.
    Matthews G; Dore G
    AIDS; 2003 Dec; 17(18):2675-6. PubMed ID: 14685063
    [No Abstract]   [Full Text] [Related]  

  • 34. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
    Ward JW
    Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral hepatitis in the elderly.
    Carrion AF; Martin P
    Am J Gastroenterol; 2012 May; 107(5):691-7. PubMed ID: 22290404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HCV burden in Europe and the possible impact of current treatment.
    Mathurin P
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S314-7. PubMed ID: 24091109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C: What lies ahead and can we afford it?
    Howie H; Hutchinson SJ
    J Viral Hepat; 2004 Sep; 11 Suppl 1():28-33. PubMed ID: 15357861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis C. Treatment and side effect management.
    Lee SP
    Adv Nurse Pract; 2003 Jul; 11(7):73-8. PubMed ID: 12886741
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C: does race really matter?
    Wiley TE
    Am J Gastroenterol; 2001 Aug; 96(8):2292-4. PubMed ID: 11513163
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinician's guide to hepatitis C.
    Gross JB
    Mayo Clin Proc; 1998 Apr; 73(4):355-60; quiz 361. PubMed ID: 9559040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.